A Phase III trial of selumetinib in patients with KRAS-mutant non small cell lung cancer
Latest Information Update: 15 Apr 2015
At a glance
- Drugs Selumetinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 15 Apr 2015 New trial record